Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Caudron

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Dermatology : EJD|May 20, 2009
Favourable progression of acquired hemophilia-associated bullous pemphigoidAnne Caudron, Denis Chatelain, Olivia Christophe, et al.
Dermatology (Basel, Switzerland)|November 14, 2008
Cytomegalovirus colitis in a patient treated with efalizumabAnne Caudron, Catherine Lok, Angèle Clabaut, et al.
Joint Bone Spine|November 6, 2007
Discitis due to Clostridium perfringensAnne Caudron, Franck Grados, Youcef Boubrit, et al.
Blood|November 22, 2014
KIR3DL2 is a coinhibitory receptor on Sézary syndrome malignant T cells that promotes resistance to activation-induced cell deathNicolas Thonnart, Anne Caudron, Isabel Legaz, et al.
European Journal of Dermatology : EJD|October 21, 2010
Multidisciplinary team meetings in Oncology: first analysis of benefits and evaluation of activity in a Dermatology unit in FranceAnne Caudron, Guillaume Chaby, Ali Dadban, et al.
Experimental Dermatology|April 10, 2016
EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanomaAnne Caudron, Maxime Battistella, Jean-Paul Feugeas, et al.
Pigment Cell & Melanoma Research|July 5, 2019
Discoidin domain receptors: A promising target in melanomaCoralie Reger de Moura, Maxime Battistella, Anjum Sohail, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Dermatology : EJD|May 20, 2009
Favourable progression of acquired hemophilia-associated bullous pemphigoidAnne Caudron, Denis Chatelain, Olivia Christophe, et al.
Dermatology (Basel, Switzerland)|November 14, 2008
Cytomegalovirus colitis in a patient treated with efalizumabAnne Caudron, Catherine Lok, Angèle Clabaut, et al.
Joint Bone Spine|November 6, 2007
Discitis due to Clostridium perfringensAnne Caudron, Franck Grados, Youcef Boubrit, et al.
Blood|November 22, 2014
KIR3DL2 is a coinhibitory receptor on Sézary syndrome malignant T cells that promotes resistance to activation-induced cell deathNicolas Thonnart, Anne Caudron, Isabel Legaz, et al.
European Journal of Dermatology : EJD|October 21, 2010
Multidisciplinary team meetings in Oncology: first analysis of benefits and evaluation of activity in a Dermatology unit in FranceAnne Caudron, Guillaume Chaby, Ali Dadban, et al.
Experimental Dermatology|April 10, 2016
EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanomaAnne Caudron, Maxime Battistella, Jean-Paul Feugeas, et al.
Pigment Cell & Melanoma Research|July 5, 2019
Discoidin domain receptors: A promising target in melanomaCoralie Reger de Moura, Maxime Battistella, Anjum Sohail, et al.
Pageof 1